Acetylmuramyl-Alanyl-Isoglutamine
"Acetylmuramyl-Alanyl-Isoglutamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Peptidoglycan immunoadjuvant originally isolated from bacterial cell wall fragments; also acts as pyrogen and may cause arthritis; stimulates both humoral and cellular immunity.
| Descriptor ID |
D000119
|
| MeSH Number(s) |
D09.067.550.050 D09.811.522.050 D12.644.233.050
|
| Concept/Terms |
Acetylmuramyl-Alanyl-Isoglutamine- Acetylmuramyl-Alanyl-Isoglutamine
- Muramyl Dipeptide
- Dipeptide, Muramyl
- Acetylmuramyl Alanyl Isoglutamine
- Alanyl Isoglutamine, Acetylmuramyl
- Isoglutamine, Acetylmuramyl Alanyl
Mur-NAc-L-Ala-D-isoGln- Mur-NAc-L-Ala-D-isoGln
- Mur NAc L Ala D isoGln
- N-Acetylmuramyl-L-Alanyl-D-Isoglutamine
- N Acetylmuramyl L Alanyl D Isoglutamine
- N-Acetyl-Muramyl-L-Alanyl-D-Glutamic-alpha-Amide
- N Acetyl Muramyl L Alanyl D Glutamic alpha Amide
|
Below are MeSH descriptors whose meaning is more general than "Acetylmuramyl-Alanyl-Isoglutamine".
Below are MeSH descriptors whose meaning is more specific than "Acetylmuramyl-Alanyl-Isoglutamine".
This graph shows the total number of publications written about "Acetylmuramyl-Alanyl-Isoglutamine" by people in this website by year, and whether "Acetylmuramyl-Alanyl-Isoglutamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Acetylmuramyl-Alanyl-Isoglutamine" by people in Profiles.
-
Cutting edge: primary innate immune cells respond efficiently to polymeric peptidoglycan, but not to peptidoglycan monomers. J Immunol. 2011 Apr 01; 186(7):3841-5.
-
Screening for potential adjuvants administered by the pulmonary route for tuberculosis vaccines. AAPS J. 2009 Mar; 11(1):139-47.